Patents by Inventor Daniel Hutta

Daniel Hutta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hetero isonipecotic modulators of vanilloid VR1 receptor
    Patent number: 8604190
    Abstract: This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to hetero isonipecotic amides that are potent modulators of VR1 which are useful for the treatment and prevention of disease conditions in mammals.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: December 10, 2013
    Assignee: Janssen Pharmaceutica NV
    Inventors: Micheal D. Gaul, Bao-Ping Zhao, Daniel A. Hutta
  • HETERO ISONIPECOTIC MODULATORS OF VANILLOID VR1 RECEPTOR
    Publication number: 20100256359
    Abstract: This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to hetero isonipecotic amides that are potent modulators of VR1 which are useful for the treatment and prevention of disease conditions in mammals.
    Type: Application
    Filed: October 6, 2009
    Publication date: October 7, 2010
    Inventors: Micheal D. Gaul, Bao-Ping Zhao, Daniel A. Hutta
  • 5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase
    Patent number: 7642270
    Abstract: The invention addresses the current need for selective and potent protein tyrosine kinase inhibitors by providing potent inhibitors of c-fms kinase. The invention is directed to the novel compounds of Formula I: or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof, wherein: W, A, Y, Z, R101 and R200 are described in the specification.
    Type: Grant
    Filed: September 12, 2006
    Date of Patent: January 5, 2010
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Mark R. Player, Hui Huang, Daniel A. Hutta, Renee L. DesJarlais
  • Hetero isonipecotic modulators of vanilloid VR1 receptor
    Patent number: 7622579
    Abstract: This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to hetero isonipecotic amides that are potent modulators of VR1 which are useful for the treatment and prevention of disease conditions in mammals.
    Type: Grant
    Filed: June 27, 2005
    Date of Patent: November 24, 2009
    Assignee: Janssen Pharmaceutica NV
    Inventors: Micheal D. Gaul, Bao-Ping Zhao, Daniel A. Hutta
  • 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE
    Publication number: 20080114007
    Abstract: The invention addresses the current need for selective and potent protein tyrosine kinase inhibitors by providing potent inhibitors of c-fms kinase. The invention is directed to the novel compounds of Formula I: or a salt, stereoisomer, tautomer, crystalline, polymorph, amorphous, solvate, hydrate, ester, prodrug or metabolite form thereof, wherein A, Y, Z, R101 and R200 are described in the specification.
    Type: Application
    Filed: October 19, 2007
    Publication date: May 15, 2008
    Inventors: Mark Player, William Parsons, Hui Huang, Daniel Hutta, Huaping Hu, James Rinker
  • 5-Oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase
    Publication number: 20070060577
    Abstract: The invention addresses the current need for selective and potent protein tyrosine kinase inhibitors by providing potent inhibitors of c-fms kinase. The invention is directed to the novel compounds of Formula I: or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof, wherein: W, A, Y, Z, R101 and R200 are described in the specification.
    Type: Application
    Filed: September 12, 2006
    Publication date: March 15, 2007
    Inventors: Mark Player, Hui Huang, Daniel Hutta
  • Hetero isonipecotic modulators of vanilloid VR1 receptor
    Publication number: 20050288281
    Abstract: This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to hetero isonipecotic amides that are potent modulators of VR1 which are useful for the treatment and prevention of disease conditions in mammals.
    Type: Application
    Filed: June 27, 2005
    Publication date: December 29, 2005
    Inventors: Michael Gaul, Bao-Ping Zhao, Daniel Hutta